Department of Neurology, St. Josef Hospital, Ruhr-University, Bochum, Germany.
Department of Neurology, Katholische Kliniken Emscher-Lippe, Germany.
Ann Clin Transl Neurol. 2020 Jun;7(6):1061-1068. doi: 10.1002/acn3.51061. Epub 2020 May 20.
We report the case of a 27-year-old patient with subacute anti-neurofascin-155 neuropathy with bifacial palsy, who showed excellent response to rituximab. We provide longitudinal data of established clinical scores, nerve conduction studies, antibody titers, and novel imaging methods (nerve ultrasonography and corneal confocal microscopy). Clinical and electrophysiological improvement followed the reduction of serum antibody titer and correlated with a reduction of corneal inflammatory cellular infiltrates whereas the increase in the cross-sectional area of the peripheral nerves remained 12 months after first manifestation. Our findings suggest that novel techniques provide useful follow-up parameters in paranodopathies.
我们报告了一例 27 岁亚急性抗神经束蛋白-155 神经病伴两面瘫患者,该患者对利妥昔单抗反应良好。我们提供了既定临床评分、神经传导研究、抗体滴度和新的成像方法(神经超声和角膜共聚焦显微镜)的纵向数据。临床和电生理改善与血清抗体滴度降低相关,与角膜炎症细胞浸润减少相关,而外周神经横截面积增加则在首次发病后 12 个月仍持续存在。我们的发现表明,新技术为副神经病变提供了有用的随访参数。